Encompass Health (EHC Quick QuoteEHC - Free Report) reported $1.59 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 9%. EPS of $1.60 for the same period compares to $1.37 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.57 billion, representing a surprise of +0.93%. The company delivered an EPS surprise of +6.14%, with the consensus EPS estimate being $1.51.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net patient revenue per discharge: $22,633.00 compared to the $22,288.83 average estimate based on two analysts.
• Discharges: 67,763 versus the two-analyst average estimate of 68,720.
• Net Operating Revenues- Net patient revenue- Inpatient: $1.53 billion versus $1.53 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.2% change.
• Net Operating Revenues- Net patient revenue- Outpatient and other: $52.9 million versus the two-analyst average estimate of $40.8 million. The reported number represents a year-over-year change of +40.3%.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned +5.4% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.